Table 3.
PI† Removal | PI Replacement | PIRR †† | Non-PIRR§ | CRSI⌷ | ||||||
---|---|---|---|---|---|---|---|---|---|---|
UVA** | MVA††† | UVA | MVA | UVA | MVA | UVA | MVA | UVA | MVA | |
HR§§ (p) | HR (p) | HR (p) | HR (p) | HR (p) | HR (p) | HR (p) | HR (p) | HR (p) | HR (p) | |
RT¶ Used | 5.52 (0.006) | 5.42 (0.003) | 1.20 (0.62) | n/a | 2.12 (0.009) | 1.35 (0.42) | 2.02 (0.066) | n/a | 1.96 (0.007) | 1.48 (0.23) |
Surgical Complication before TE# /PI Exchange | 3.89 (0.013) | 2.28 (0.17) | 0.95 (0.93) | n/a | 1.61 (0.24) | n/a | 0.36 (0.29) | n/a | 1.26 (0.53) | n/a |
Silicone vs. Saline Implant | 1.21 (0.71) | n/a | 2.25 (0.012) | 2.80 (0.006) | 1.93 (0.025) | 1.65 (0.10) | 2.07 (0.057) | n/a | 2.08 (0.004) | 2.23 (0.003) |
Nipple Reconstruction Performed | 0.48 (0.18) | n/a | 2.1 (0.027) | 2.61 (0.006) | 1.49 (0.16) | n/a | 3.64 (0.0016) | n/a | 1.84 (0.012) | 2.31 (0.001) |
Age ≤45 Years vs. >45 Years | 1.01 (0.61) | n/a | 1.96 (0.021) | 1.69 (0.11) | 1.03 (0.015) | 1.02 (0.16) | 1.15 (0.74) | n/a | 1.63 (0.041) | 1.02 (0.18) |
Chemotherapy Used | 2.20 (0.22) | n/a | 1.79 (0.13) | n/a | 2.02 (0.018) | 1.45 (0.29) | 1.29 (0.74) | n/a | 1.68 (0.037) | 1.27 (0.42) |
Stage III vs. 0/I/II | 4.10 (0.25) | n/a | 1.04 (0.95) | n/a | 3.43 (0.033) | 1.27 (0.59) | 0.88 (0.86) | n/a | 4.33 (0.032) | 1.23 (0.61) |
KEY:
= Permanent Implant,
= Permanent Implant Replacement or Removal,
= Complication Requiring Surgery other than Implant Replacement or Removal,
= Complication Requiring Surgical Intervention,
= Radiation Therapy,
= Tissue Expander,
= Univariate Analysis,
= Multivariate Analysis,
= Hazard Ratio.
Significant findings are bolded and italicized.